Floatz logo

Docetaxel

HER2 Positive Breast Carcinoma

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
70/ 100
Competitive Position
65/ 100

Competitive context

175 Active assets in the HER2 Positive Breast Carcinoma cohort.

Asset / SponsorPhaseRating
Trastuzumab
SWOG Cancer Research Network
Phase 4BB
Pertuzumab
SWOG Cancer Research Network
Phase 4BB
Ribociclib
Danish Breast Cancer Cooperative Group
Phase 3BB
Cyclophosphamide
National University Hospital, Singapore
Phase 3BB
Capecitabine
MedSIR
Phase 4BB

View all 50 →

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmActive
BBB
Indicative · Phase 4
73 / 100
View asset →
pancreatic adenocarcinomaActive
BBB
Indicative · Phase 2
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative · Phase 2
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →